Translational Research in Lung Cancer: Biological Basis of Cancer Disparities in African Americans

Funding Agency:
V Foundation

On behalf of The V Foundation for Cancer Research, in partnership with the Lung Cancer Initiative of North Carolina, we would like to announce an opportunity to submit a grant proposal in the area of Lung Cancer Translational/ Clinical Trials Research. Our primary interest is to fund projects which support new or existing lung cancer clinical trials in North Carolina. We are also interested in translational research proposals with specific research aims that are moving toward initiating a near-term clinical trial or include correlative studies for an existing clinical trial. Each submitted proposal (existing clinical trial or translational research toward a clinical trial) must include a component which recognizes and addresses the disparities in cancer incidence and death rates in African Americans, as compared to all other ethnic groups. For example, this component of the application can include a specific aim to better understand the biological basis of these disparities or it may include a plan to increase outreach to African American patients who can benefit from enrollment in the clinical trial.

Duke has been invited to submit a maximum of two nominees for consideration for this Designated Award.


  • Duke Internal Deadline: April 17, 2018
  • Nomination Materials Due to Sponsor: May 1, 2018
  • Application Materials Due to Sponsor: June 1, 2018

Agency Website

Eligibility Requirements

Applicant Eligibility: Your nominated applicant(s) must meet all of the following criteria to be eligible to submit an application:

  • Nominees must be nominated by their Cancer Center Director if the research institution is a cancer center. If the research institution is not a cancer center, then the provost, dean or other senior research administrative official who is responsible for the internal nominee selection process may make the nomination. We do not review unsolicited applications.
  • Applicant (nominated PI) must be employed at a non-profit research institution (e.g. 501c3, Section 170).
  • NOTE: Applicants who received awards in 2017 may apply for additional funding.
  • All levels of investigators, including early investigators, are encouraged to apply



Amount Description

Depending on the outcome of scientific review of the submitted proposals, a maximum of one grant will be awarded through this grant cycle. The grant awarded will be a three year grant of $300,000 ($100,000 per year) to support direct costs only.

Funding Type





Medical - Clinical Science
Medical - Translational

Internal Nomination

The DCI is invited to submit up to two nominees, thus will be conducting an internal review of applications. The following items are required and will be reviewed by the DCI’s Scientific Review Committee.

1. Applicant’s NIH Biosketch

2. Two (2) page summary including the following information:

* Title of the proposed research project

* Brief description of the research proposal

* Brief statement of applicant’s eligibility

Applications for internal review are due to Erin Carr ( no later than Tuesday, April 17th  (please send your application in one PDF).  Selected nominees will be notified by Tuesday, April 24th.

Internal Deadline

April 17, 2018

External Deadline

May 1, 2018